Aerosol clearance in patients with and without long COVID

Not Applicable

• Conditions: ong COVID; Infections and Infestations

• Registration Number: ISRCTN11309292
• Lead Sponsor: HS Tayside

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-06-01
• Last Update Posted: 5 August 2022
• Study Completion: 2023-12-01

Recruitment & Eligibility

• Status: Ongoing
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

1. Patients referred to the Department of Nuclear Medicine, Ninewells Hospital, Dundee for a lung V/Q scan as part of their standard of care
2. Participants must be 18 years old or above

Exclusion Criteria

1. Below 18 years of age
2. Pregnant
3. Lack of capacity to provide informed consent
4. Involved in current research or have recently been involved in any research prior to recruitment

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The clearance half time of [99mTc]DTPA aerosol from the lungs measured by lung scintigraphy on the day of recruitment in non-smoking patients with a clinical history of long COVID

Secondary Outcome Measures

Name	Time	Method
The clearance half time of [99mTc]DTPA aerosol from the lungs measured by lung scintigraphy on the day of recruitment in:<br>1. Smoking patients with a clinical history of long COVID<br>2. Non-smoking patients with no history of interstitial lung or airways disease<br>3. Smoking patients with no history of interstitial lung or airways disease